A detailed history of State Street Corp transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, State Street Corp holds 1,050,420 shares of INZY stock, worth $3.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,050,420
Previous 1,000,034 5.04%
Holding current value
$3.14 Million
Previous $4.46 Million 23.16%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.31 - $6.0 $217,163 - $302,316
50,386 Added 5.04%
1,050,420 $5.49 Million
Q2 2024

Aug 14, 2024

BUY
$4.33 - $7.31 $516,980 - $872,777
119,395 Added 13.56%
1,000,034 $4.46 Million
Q1 2024

May 15, 2024

BUY
$4.14 - $7.66 $555,198 - $1.03 Million
134,106 Added 17.96%
880,639 $6.75 Million
Q4 2023

Feb 14, 2024

BUY
$2.71 - $4.5 $320,284 - $531,837
118,186 Added 18.81%
746,533 $3.18 Million
Q3 2023

Nov 14, 2023

BUY
$4.09 - $7.0 $276,095 - $472,535
67,505 Added 12.04%
628,347 $2.64 Million
Q2 2023

Aug 14, 2023

BUY
$4.93 - $6.74 $2.28 Million - $3.12 Million
462,787 Added 471.97%
560,842 $3.12 Million
Q1 2023

May 15, 2023

BUY
$1.3 - $5.73 $28,210 - $124,341
21,700 Added 28.42%
98,055 $561,000
Q3 2022

Nov 15, 2022

BUY
$2.57 - $5.45 $70,161 - $148,785
27,300 Added 55.65%
76,355 $205,000
Q2 2022

Aug 15, 2022

SELL
$3.2 - $5.96 $447,840 - $834,102
-139,950 Reduced 74.05%
49,055 $234,000
Q1 2022

May 16, 2022

BUY
$3.87 - $7.55 $7,364 - $14,367
1,903 Added 1.02%
189,005 $773,000
Q4 2021

Feb 14, 2022

SELL
$5.58 - $11.5 $6,500 - $13,397
-1,165 Reduced 0.62%
187,102 $1.28 Million
Q3 2021

Nov 15, 2021

BUY
$11.12 - $19.4 $204,363 - $356,533
18,378 Added 10.82%
188,267 $2.18 Million
Q2 2021

Aug 16, 2021

BUY
$15.19 - $21.2 $572,207 - $798,604
37,670 Added 28.49%
169,889 $2.9 Million
Q1 2021

May 17, 2021

BUY
$17.77 - $27.9 $260,152 - $408,456
14,640 Added 12.45%
132,219 $2.62 Million
Q4 2020

Feb 16, 2021

BUY
$19.95 - $27.55 $937,530 - $1.29 Million
46,994 Added 66.58%
117,579 $2.43 Million
Q3 2020

Nov 10, 2020

BUY
$17.54 - $30.2 $1.24 Million - $2.13 Million
70,585 New
70,585 $1.86 Million

Others Institutions Holding INZY

About Inozyme Pharma, Inc.


  • Ticker INZY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,145,700
  • Market Cap $120M
  • Description
  • Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...
More about INZY
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.